Convoke is a seed-stage biotech software startup based in South San Francisco, building an AI-powered “autonomy stack” to accelerate drug development by automating complex decision-making workflows and integrating fragmented scientific, clinical, and regulatory data. Their platform enables biopharma companies to move from idea to product at the speed of silicon, streamlining tasks like data sourcing, trial design, and launch planning. Founded in 2024 and backed by top-tier investors, Convoke leverages deep industry expertise to address critical bottlenecks in drug development, aiming to dramatically improve efficiency and success rates across the biopharma sector.